Yuheng Pharmaceutical: Guolei Peak and Tibet Yupan jointly increased their holdings by 1.12%.

Yu Heng Pharmaceutical announced that the company's director, general manager, and chief financial officer Guo Leifeng and the concerted action person Tibet Yupan acquired a total of 25 million shares of the company in a judicial auction on Taobao from 10:00 on November 20, 2025 to 10:00 on November 21, 2025, accounting for 1.12% of the total share capital. Among them, Guo Leifeng increased his holdings by 20 million shares, reaching 41.98 million shares or 1.88% of the total shares; Tibet Yupan increased its holdings by 5 million shares, reaching 5 million shares or 0.22% of the total shares. The total holdings amount to 46.98 million shares or 2.10%.